Del 62 - Annual Reports in Medicinal Chemistry

Annual Reports in Medicinal Chemistry: Roadmaps

Inbunden, Engelska, 2024

2 499 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. This release provides a compendium of information on newly approved drugs and compounds entering late-stage clinical trials, making it a valuable resource for graduate students pursuing research in medicinal chemistry

Reviews on hot topics of interest in small molecule drug discovery heavily pursued by industrial research organizations
Provides preclinical information in the context of chemical structures
Includes section editors who are highly knowledgeable and who can evaluate invited reviews for scientific rigor

Produktinformation

Utgivningsdatum2024-11-05
Mått152 x 229 x undefined mm
Vikt660 g
FormatInbunden
SpråkEngelska
SerieAnnual Reports in Medicinal Chemistry
Antal sidor328
FörlagElsevier Science
ISBN9780443296109

Tillhör följande kategorier

Kemi inom Naturvetenskap och teknik
Farmakologi inom Medicin

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach tonucleoside, nucleotide and heterocyclic drug discovery and development with therapeuticemphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currentlyused drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served asthe Program Director for UMBC’s Chemistry-Biology Interface graduate training programfunded by NIH since 2007. This program promotes hands on cross disciplinary research foralmost 50 PhD students from four departments at UMBC and UMB. She is currently theImmediate Past President and Secretary-Elect for the International Society of Nucleosides,Nucleotides and Nucleic Acids and a Board member of the International Society for AntiviralResearch. Prof. Seley-Radtke also serves as a standing member for several NIH study sectionsand is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy,Molecules – Chemical Biology, and Current Protocols in Chemical Biology.